In summary, ALS variants were poor inducers of Hspa1a expression; RGFP963 slightly improved this response in motor neurons expressing TDP-43 and SOD1 variants, but arimoclomol was significantly effective only in the SOD1 model. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.